The active ingredient of CloSTAT™ – a unique strain of Bacillus subtilis PB6 – has received full approval from the European Commission after a positive assessment by EFSA and approval by the Standing Committee on the Food Chain and Animal Health.
CloSTAT™ active microbial contains a unique strain of Bacillus subtilis PB6 that was isolated and selected from the gut of healthy chicken. CloSTAT™ has targeted activity against Clostridium, a major organism responsible for disturbing animal health.
Athan Katsanos, President of Kemin Agrifoods Europa: “With CloSTAT™ the poultry industry has access to a novel and reliable strategy to raise broilers in healthy conditions.”
As a natural solution to support animal health, CloSTAT™ maintains a balanced gastro intestinal tract and has demonstrated its efficacy to raise poultry in a natural environment, reducing mortality and lesion scores due to necrotic enteritis, the company reports.
Numerous research and field research trials have demonstrated that CloSTAT™ is a reliable solution to maintain a balanced gastro intestinal tract. Consequently lower mortalities, increases in body weight and improved feed conversion are returned upon CloSTAT™.
Source: Kemin Agrifoods Europa